Month: April 2024

Vancouver, B.C., April 08, 2024 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62) is pleased to provide this operational update for the SASB gas field. Trillion is starting the SASB revitalization project now as all relevant equipment and supplies for the start of the operations arrive mid-April 2024. As mentioned previously a total of 49 metres of new gas pay will be perforated in Guluc-2, South Akcakoca-2, West Akcakoca-1 and Akcakoca-3 prior to the installation of the artificial gas lift (AL). Shifting the start of the SASB revitalization project from the end of the 1st Qtr. to the beginning of the 2nd Qtr. was the result of “the only solution is the correct solution”. Previously, the SASB AL program consisted of PCP pumps, ESP pumps and velocity strings....

FREMONT, Calif., April 08, 2024 (GLOBE NEWSWIRE) — AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor substrates, today announced that it expects to report revenue in the range of $22.4 to $22.7 million for the first quarter ended March 31, 2024, exceeding the company’s prior guidance for the first quarter of 2024 of $20 million to $22 million. This reflects growth in demand for both indium phosphide and gallium arsenide substrates for a variety of applications, including artificial intelligence/data center connectivity, infrastructure, wireless devices, industrial lasers, and others. The company will announce its financial results for the first quarter of 2024 in a press release immediately following the close of market on May 2, 2024. It will also host a conference call to discuss these results on May...

BERKELEY HEIGHTS, N.J., April 08, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a 5-year commercial supply contract with Florida-based dialysis provider, ARC Dialysis, LLC for the supply of DefenCath® (taurolidine and heparin). CorMedix received NDA approval of DefenCath® under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) on November 15, 2023, and expects to begin commercialization of the product in the inpatient setting on April 15th. CorMedix is committed to building meaningful long-term relationships with dialysis providers that are dedicated to innovation and infection reduction. ARC Dialysis, a Miami-based medium-sized dialysis...

Profitable Acquisition Expected to Contribute More than $8 Million of Annualized Revenue and Over $1 Million of Adjusted EBITDA MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a definitive agreement to acquire Purely Optimal Nutrition, a premier eCommerce nutraceuticals company with operations in North America. A.J. Cervantes, Jr., Smart for Life’s founder and Chairman, stated, “We are very excited to have Purely Optimal join forces under the Smart for Life umbrella. Purely Optimal’s product line is designed to yield optimal results with carefully sourced and nourishing ingredients from all around the world....

– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activation of immune cells and increased cytokine secretion –– Mechanism may enhance antitumor responses with immunotherapy –– First novel immuno-oncology product candidate discovered and developed by Coherus –– The CHS-1000 IND submission is planned for Q2 2024 – REDWOOD CITY, Calif., April 08, 2024 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today presented preclinical data for its immuno-oncology pipeline candidate, CHS-1000, a novel ILT4 monoclonal antibody, at the 2024 AACR Annual Meeting being held in San Diego, California. Data presented show CHS-1000 is a potent monoclonal antibody that binds selectively to human ILT4 (also known as LILRB2) with high affinity,...

Subsidiary NetNut’s revenues surged approximately 140% in the first quarter of 2024 compared to the equivalent period in 2023  Tel Aviv, Israel, April 08, 2024 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, today provided preliminary key financial metrics guidance for the three months ended on March 31, 2024. Based on a preliminary, unaudited review, Alarum anticipates reporting strong performance for the first quarter of 2024, highlighting accelerated operating and business growth:Revenue for the first quarter of 2024 is estimated at more than $8.3 million, representing the highest quarterly revenue achievement to date and an estimated increase of close to 50% compared to the same period in 2023. In the first...

Bids in the nominal amount of 37,000 m.kr. were submitted for RIKV 24 0717, and bids in the nominal amount of 26,000 m.kr. were accepted at the price of 97.482 and simple interest of 9.489%. Bids in the nominal amount of 25,045 were submitted for RIKV 24 1016, and bids in the nominal amount of 16,895 were accepted at the price of 95.249 and simple interest of 9.501%.

TOKYO, April 08, 2024 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo, today announced that Booking.com had awarded the Company the Traveller Review Award 2024 for the ENT TERRACE AKIHABARA Hotel, with a rating of 9.5 out of 10. Booking.com’s Traveller Awards is an esteemed list of international properties based on over 308 million customer reviews. Review scores for this award are based on the average of all customer reviews published on the Bookings.com website and app between December 1, 2020 and November 30, 2023. The final review score was calculated on December 1, 2023, based on reviews received in the previous three years.   “Booking.com’s...